Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Phase 2 Study of MD-1100 Acetate on Gastrointestinal Transit in Patients With C-IBS
This study has been completed.
Study NCT00258193 Information provided by Ironwood Pharmaceuticals, Inc.
First Received on November 22, 2005. Last Updated on October 19, 2006
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Irritable Bowel Syndrome
Additional conditions recognized in this trial
More general conditions related to this trial
Colonic Diseases, Functional
Digestive System Diseases
Signs and Symptoms
Signs and Symptoms, Digestive
Interventions listed in this trial
Sponsors listed in this trial
Ironwood Pharmaceuticals, Inc.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers